About: Dietmar Hopp

Coronavirus 15-06-2020

German government takes a stake in vaccine developer CureVac

In the global race for a coronavirus vaccine, the German government is investing €300 million and acquiring a stake in the biotech company CureVac, regarded as one of the leaders in the development of a vaccine in Germany. EURACTIV Germany reports.
Contribute